290 results
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
2 May 24
Lexicon Pharmaceuticals Reports First Quarter 2024
4:07pm
launch, with the expansion of market access we expect to begin around the middle of this year enabling an inflection in the second half of the year,” said … negotiations with payers regarding expanded market access. Net sales for the quarter were $1.1 million reflecting 63 percent growth from the previous
8-K
EX-10.1
3v7ei
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-99.1
6w6qdyudw
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-1.1
nas3w jy77id7
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
cz6h balvk2de9q
29 Dec 23
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
n43co0
8 Nov 23
Lexicon Pharmaceuticals Reports Third Quarter 2023
7:22am
8-K
EX-99.1
bnmx2wkakg3l
31 Jul 23
Lexicon Elects Diane E. Sullivan to Board of Directors
4:02pm
8-K
EX-1.1
h5ky4xu4acsfkmydm
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
dev33 6asvy
1 Jun 23
Prospectus supplement for primary offering
9:08pm
8-K
9rb0qxr9du eqb3c
31 May 23
Lexicon Announces Proposed Public Offering of Common Stock
4:17pm
424B5
bnlus4h x67wytz1
31 May 23
Prospectus supplement for primary offering
4:07pm